| Leveraging multi-organ models for drug combination therapy safety | Biomedicine & pharmacotherapy |  | | 2025 | 30 | 66 |
|
| Generation and maintenance of kidney and kidney cancer organoids from patient-derived material for drug development and precision oncology | Molecular therapy. Methods & clinical development | | | 2024 | 62 | 54 |
|
